BELLICUM PHARMACEUTICALS INC (BLCM)
Institutional ownership reported to the SEC as of Q2 2023, across 19 quarters.
4
Reporting holders
$6.6K
Reported value
0.0%
Held as options
-16
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| B. Riley Wealth Advisors, Inc. | $4.2K | 11,420 | 0.00% | new | NEW |
| Tekla Capital Management LLC | $2.2K | 6,000 | 0.00% | 14q | HELD |
| Boxer Capital, LLC | $167 | 450,000 | 0.01% | new | NEW |
| Princeton Global Asset Management LLC | $37 | 100 | 0.00% | 2q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2023 | 4 | $6.6K | 467,520 | 2 | 0 | 0 | 0.0% |
| Q1 2023 | 20 | $462.4K | 1,401,301 | 1 | 3 | 3 | 0.0% |
| Q4 2022 | 25 | $1.1M | 1,550,961 | 7 | 4 | 1 | 0.0% |
| Q3 2022 | 22 | $2.1M | 1,774,106 | 1 | 3 | 4 | 0.0% |
| Q2 2022 | 23 | $2.2M | 1,871,363 | 2 | 4 | 4 | 0.0% |
| Q1 2022 | 23 | $3.8M | 1,737,579 | 6 | 4 | 3 | 0.0% |
| Q4 2021 | 18 | $2.2M | 1,468,415 | 1 | 1 | 3 | 0.0% |
| Q3 2021 | 22 | $4.5M | 1,536,268 | 1 | 4 | 6 | 0.0% |
| Q2 2021 | 24 | $5.1M | 1,554,588 | 3 | 4 | 8 | 0.0% |
| Q1 2021 | 23 | $5.1M | 1,367,746 | 4 | 5 | 3 | 0.0% |
| Q4 2020 | 27 | $5.8M | 1,630,916 | 12 | 2 | 7 | 0.0% |
| Q3 2020 | 18 | $6.7M | 1,019,341 | 2 | 3 | 7 | 0.0% |
| Q2 2020 | 27 | $11.4M | 1,034,029 | 6 | 4 | 6 | 32.8% |
| Q1 2020 | 30 | $10.6M | 1,725,478 | 28 | 0 | 1 | 23.6% |
| Q4 2019 | 49 | $23.5M | 17,905,229 | 4 | 14 | 13 | 1.6% |
| Q3 2019 | 64 | $21.1M | 19,741,326 | 9 | 15 | 25 | 1.6% |
| Q2 2019 | 77 | $43.4M | 24,820,420 | 11 | 25 | 21 | 0.4% |
| Q1 2019 | 92 | $85.3M | 25,254,666 | 11 | 24 | 24 | 0.2% |
| Q4 2018 | 92 | $70.2M | 24,030,577 | 2 | 1 | 1 | 0.1% |